Aventis Behring Launches New Global Web Site; Range of Tools Simplifies Information Gathering for Customers and Plasma Donors.Business Editors/Health/Medical Writers KING OF PRUSSIA King of Prussia, industrialized suburban area (1990 pop. 18,406), Montgomery co., SE Pa. It has glass and steel fabricating, food processing, printing and publishing, and varied manufacturing (textiles, liquified petroleum gas, water-treatment and electrical , Penn.--(BUSINESS WIRE)--May 8, 2003 Aventis Behring L.L.C., a global leader in the plasma protein plasma protein n. Any of the various dissolved proteins of blood plasma, including antibodies and blood-clotting proteins, that act by holding fluid in blood vessels by osmosis. industry, announced today the debut of its newly designed Web site, which is designed to provide patients and their families, healthcare professionals and plasma donors easy access to information about the company's products, resources, programs and plasma donation network. "Aventis Behring is strongly committed to being a resource for our customers and plasma donors. Our Web site reflects this philosophy as we focused on building specific sections tailored to each of these audiences. This new design should enable them to easily access the latest information on our life-saving products, services and plasma collections centers," said June Wispelwey, Vice President, Marketing Services, Aventis Behring. "Further, we believe that the site will not only enhance existing customer relationships, but also will cultivate new ones." Located at http://www.AventisBehring.com, the Web site has a fresh, new design that offers customers a more intuitive Internet experience. For example, content now is available in easy-to-read "newspaper" format with a larger font size; search engine results are enhanced; site navigation is made simpler by embedded cross-linking; links to other Web sites are easy to access; user-friendly links are available to Aventis Behring divisions in the U.S., U.K., Germany, Japan, Brazil, Austria, and the Nordic region, where company information is provided in the local language; and a cross-cultural design demonstrates the company's philosophy about caring for its customers worldwide. (Aventis Behring divisions such as Italy, Switzerland and Canada, among others, will also be adopting this design soon.) The site also includes these enhancements: -- Revamped front page - Users have quick access to the latest events and news releases from Aventis Behring, links to all products sold in the U.S. (and related prescribing information), and links to programs and services for patients and families, physicians and healthcare professionals, and plasma donors. -- Educational materials - This section allows users to order a variety of educational resources on a wide range of topics relevant to the bleeding disorders Bleeding disorder Problems in the clotting mechanism of the blood. Mentioned in: Lithotripsy bleeding disorder Coagulopathy, see there community. -- Corporate and R&D information - This section provides detailed information about Aventis Behring's history dating back to 1885, worldwide locations and global product portfolio as well as information about new products in development and quality and safety standards Safety standards are standards designed to ensure the safety of products, activities or processes, etc. They may be advisory or compulsory and are normally laid down by an advisory or regulatory body that may be either voluntary or statutory. . -- Global product portfolio - This section features a comprehensive list of Aventis Behring's global products organized according to according to prep. 1. As stated or indicated by; on the authority of: according to historians. 2. In keeping with: according to instructions. 3. the company's four areas of expertise: bleeding disorders, immune deficiency immune deficiency n. See immunodeficiency. , critical care and wound healing. -- Dedicated media room - Members of the media who are looking for information ranging from plasma donation to new product development, or the latest on company executives, can visit this site for easy-to-access press releases, press kits, backgrounders, biographies, and photos. About Aventis Behring Aventis Behring, part of the Aventis family of companies, is a global leader in the plasma protein industry, providing a wide range of innovative and high-quality medicines to patients worldwide. Aventis Behring is dedicated to research and development in the area of human blood plasma blood plasma n. The yellow or gray-yellow, protein-containing fluid portion of blood in which the blood cells and platelets are normally suspended. as well as in emerging technologies. For more information about Aventis Behring, please visit: www.AventisBehring.com. Aventis (NYSE NYSE See: New York Stock Exchange : AVE) is dedicated to treating and preventing disease by discovering and developing innovative prescription drugs prescription drug Prescription medication Pharmacology An FDA-approved drug which must, by federal law or regulation, be dispensed only pursuant to a prescription–eg, finished dose form and active ingredients subject to the provisos of the Federal Food, Drug, and human vaccines. In 2002, Aventis generated sales of EUR EUR In currencies, this is the abbreviation for the Euro. Notes: The currency market, also known as the Foreign Exchange market, is the largest financial market in the world, with a daily average volume of over US $1 trillion. 17.6 billion, invested EUR3.1 billion in research and development and employed approximately 71,000 people in its core business. Aventis corporate headquarters are in Strasbourg, France. For more information, please visit: www.aventis.com. Statements in this news release other than historical information are forward-looking statements forward-looking statement A projected financial statement based on management expectations. A forward-looking statement involves risks with regard to the accuracy of assumptions underlying the projections. subject to risks and uncertainties. Actual results could differ materially depending on factors such as the availability of resources, the timing and effects of regulatory actions, the strength of competition, the outcome of litigation An action brought in court to enforce a particular right. The act or process of bringing a lawsuit in and of itself; a judicial contest; any dispute. When a person begins a civil lawsuit, the person enters into a process called litigation. and the effectiveness of patent protection. Additional information regarding risks and uncertainties is set forth in the current Annual Report on Form 20-F of Aventis on file with the Securities and Exchange Commission. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion